收藏切换
Synthesis Route Selection and Process Development of a Novel SGLT2 Inhibitor Olorigliflozin
收藏切换
Zheng GU1, 2, Wuyong WU1, Zheng LI1, Zongyuan ZHANG1, Tianyun WU1, Ji ZHANG1, 2, *
Chinese Journal of Pharmaceuticals | 2025, 56(2) : 170 - 181
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(2): 170-181
• Paper •
Synthesis Route Selection and Process Development of a Novel SGLT2 Inhibitor Olorigliflozin
Full
Zheng GU1, 2, Wuyong WU1, Zheng LI1, Zongyuan ZHANG1, Tianyun WU1, Ji ZHANG1, 2, *
Affiliations
  • 1.HEC Pharmaceutical Research Institute, HEC Pharm Group, Dongguan 523871
  • 2.State Key Lab. of Anti-Infective Drug Discovery and Development, Sunshine Lake Pharma Co., Ltd., Dongguan 523871
Published: 2025-02-10 doi: 10.16522/j.cnki.cjph.2025.02.004
Outline
收藏切换

Olorigliflozin(1) is a novel sodium-glucose linked transporter 2(SGLT2) inhibitor. Its synthesis strategies, process development and route selection were analyzed and summarized. According to the different raw materials, there were route one(pyranose intermediate A-1 was used for the synthesis) and route two(ring-opening intermediate B-1 was used for the synthesis) for the overall synthesis of 1 . And route two could be divided into route① and route② according to the amount of separatable intermediates. By screening suitable protecting groups, the route②(10 steps) avoided the use of hazardous reagents and ultra-low temperature reactions, which was more easily to separate and purify through the telescoping process. The total yield of the roud② was 24.2% with the purity of 99.72%. This route hold controllable quality and high stereoselectivity, which is suitable for industrial production. At present, it has successfully prepared 1 in kilograms and above.

olorigliflozin  /  antihyperglycemics  /  sodium-glucose linked transporter 2 inhibitor  /  diabetes mellitus  /  process development  /  synthetic route
顾峥, 伍武勇, 李峥, 张宗远, 吴天云, 张霁. 新颖的SGLT2抑制剂奥洛格列净的合成路线选择与工艺研发. 中国医药工业杂志, 2025 , 56 (2) : 170 -181 . DOI: 10.16522/j.cnki.cjph.2025.02.004
Zheng GU, Wuyong WU, Zheng LI, Zongyuan ZHANG, Tianyun WU, Ji ZHANG. Synthesis Route Selection and Process Development of a Novel SGLT2 Inhibitor Olorigliflozin[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (2) : 170 -181 . DOI: 10.16522/j.cnki.cjph.2025.02.004
Year 2025 volume 56 Issue 2
33
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.02.004
  • Receive Date:2024-11-11
  • Online Date:2026-11-17
  • Published:2025-02-10
Article Data
Affiliations
History
  • Received:2024-11-11
Funding
Affiliations
    1.HEC Pharmaceutical Research Institute, HEC Pharm Group, Dongguan 523871
    2.State Key Lab. of Anti-Infective Drug Discovery and Development, Sunshine Lake Pharma Co., Ltd., Dongguan 523871
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.02.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT